Hospital Expansion Funding
Advent International Invests Rs 3,150 Crore in Yatharth Hospitals for Expansion
Anonymous
Key Points
1
The preferential allotment consists of up to 13,026,516 equity shares worth ₹1,283.33 crore and 18,947,664 warrants worth ₹1,866.67 crore, with both instruments priced at ₹985.17 each.
2
Advent’s investment will be made through Cyprus-incorporated Rasmalai Limited, which is expected to hold a 24.87% post-issue stake on a fully diluted basis.
3
Yatharth currently operates nine multispecialty hospitals with roughly 2,800 beds and has announced capacity of about 3,250 beds across locations including Noida, Greater Noida, Agra, Faridabad, New Delhi and Jhansi-Orchha.
4
The company said newer facilities are ramping up quickly: its Faridabad Sector-20 unit reached EBITDA breakeven within nine months, while the Agra hospital exceeded a 20% EBITDA margin in its first full quarter.
5
Advent Managing Director Pankaj Patwari said the investment reflects the firm’s “deep and longstanding commitment to India’s healthcare sector,” while Yatharth Whole-time Director Yatharth Tyagi said the partnership would bring healthcare expertise, global insights and a value-creation approach; the transaction remains subject to customary closing conditions.
Advent International, a major global private equity firm, will invest ₹3,150 crore in Yatharth Hospitals to acquire a 24.9% minority stake, according to The Hindu. The investment comes through a preferential share allotment and marks a significant vote of confidence in North India's fast-growing hospital chain, which reported 52% revenue growth in the first quarter of fiscal 2027.
Yatharth's founding Tyagi family will remain the largest shareholder and retain strategic control. The hospital chain plans to use the capital for acquisitions and expansion across North India, targeting around 5,000 operational beds by fiscal 2029, up from roughly 2,800 beds today.
Deal Structure and Investment Details
Advent will inject the capital through Rasmalai Limited, a Cyprus-based investment vehicle, according to Equity Pandit. The ₹3,150 crore package consists of 13,026,516 equity shares worth ₹1,283.33 crore and 18,947,664 warrants worth ₹1,866.67 crore. Both instruments are priced at ₹985.17 each.
Post-completion, Rasmalai will hold a 24.87% stake on a fully diluted basis, Times Now News reports. The transaction remains subject to customary closing conditions. Stock markets responded positively, with Yatharth's shares jumping 10% on the deal announcement.
Strong Financial Performance Drives Investment Appeal
Yatharth's first-quarter fiscal 2027 results underscore why Advent sees opportunity. Revenue jumped 52% year-over-year to ₹392.65 crore, while net profit climbed nearly 12% to ₹47.06 crore, showing both explosive top-line growth and bottom-line profitability.
Newer facilities are ramping up faster than typical for hospital chains. The Faridabad Sector-20 unit reached EBITDA breakeven in just nine months, while the Agra hospital exceeded a 20% EBITDA margin in its first full quarter of operation.
Expansion Blueprint Targets Five Major North Indian Hubs
Yatharth currently operates nine multispecialty hospitals with roughly 2,800 beds across six North Indian locations: Noida, Greater Noida, Agra, Faridabad, New Delhi, and Jhansi-Orchha. Announced capacity stands at about 3,250 beds today.
The capital from Advent will accelerate growth toward 5,000 beds by fiscal 2029 through both new hospital builds and acquisitions. Trade Brains noted the deal aligns with Yatharth's long-term strategy to become a dominant regional healthcare player in North India.
Private Equity Sees Health-Care Tailwinds in India
Advent Managing Director Pankaj Patwari framed the investment as reflecting the firm's "deep and longstanding commitment to India's healthcare sector." India's hospital industry is expanding rapidly as middle-class healthcare spending grows and tier-2 cities build capacity.
Yatharth Whole-time Director Yatharth Tyagi said the partnership would bring "healthcare expertise, global insights and a value-creation approach" to accelerate growth. The Tyagi family's continued majority stake ensures founder-led strategy and long-term alignment with Advent's expansion vision.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
23
Articles
97
Reach
120
A
AnonymousAuthor
